Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 160,711 | 25,086 | -875,097 | 148,090 | 101,659 |
| Depreciation Amortization | 402,208 | 439,435 | 61,308 | 10,156 | 6,306 |
| Income taxes - deferred | -115,539 | -135,553 | -27,267 | -39,922 | 60,431 |
| Accounts receivable | -8,518 | -76,529 | 22,618 | -3,927 | 704 |
| Other Working Capital | 139,776 | 258,714 | -127,416 | -60,068 | -19,640 |
| Other Operating Activity | 310,865 | 216,833 | 1,115,821 | 142,390 | 4,854 |
| Operating Cash Flow | $889,503 | $727,986 | $169,967 | $196,719 | $154,314 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 89,754 | -361,013 | -301,248 | -165,904 | -67,380 |
| Net Acquisitions | N/A | N/A | 136,793 | N/A | N/A |
| Purchase Of Investment | -1,454,147 | -3,213,051 | -1,233,251 | -1,514,475 | -671,392 |
| Sale Of Investment | 1,782,134 | 3,200,386 | 1,118,775 | 841,225 | 582,052 |
| Purchase Sale Intangibles | N/A | -8,750 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -8,750 | 22,500 | -17,498 | 0 |
| Investing Cash Flow | $417,741 | $-382,428 | $-256,431 | $-856,652 | $-156,720 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -9,639 | 9,931 | 26,746 | 696,004 | N/A |
| Debt Repayment | -746,416 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 119,619 | 273,535 | 24,439 | 23,059 | 28,096 |
| Common Stock Repurchased | -322,590 | -734,427 | N/A | -135,000 | N/A |
| Other Financing Activity | 10,503 | 0 | 0 | 0 | -743 |
| Financing Cash Flow | $-948,523 | $-450,961 | $51,185 | $584,063 | $27,353 |
| Beginning Cash Position | 209,447 | 314,850 | 350,129 | 425,999 | 401,052 |
| End Cash Position | 568,168 | 209,447 | 314,850 | 350,129 | 425,999 |
| Net Cash Flow | $358,721 | $-105,403 | $-35,279 | $-75,870 | $24,947 |
| Free Cash Flow | |||||
| Operating Cash Flow | 889,503 | 727,986 | 169,967 | 196,719 | 154,314 |
| Capital Expenditure | -318,376 | -361,013 | -301,248 | -165,904 | -67,380 |
| Free Cash Flow | 571,127 | 366,973 | -131,281 | 30,815 | 86,934 |